While DOACs are generally safe, they are not without risks. The primary concern is the increased risk of bleeding, which is a potential side effect of all anticoagulants. Cancer patients may already be at a higher risk for bleeding due to the cancer itself or treatments such as chemotherapy. Therefore, it is crucial to carefully assess the risk-benefit ratio for each patient before initiating DOAC therapy.
